Headlands Technologies’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$159K Buy
29,292
+12,232
+72% +$46.9K 0.02% 627
2026
Q1
$38.9K Sell
17,060
-57,724
-77% -$183K ﹤0.01% 704
2025
Q4
$299K Buy
+74,784
New +$416K 0.03% 520
2025
Q3
Sell
-5,120
Closed -$57.7K 830
2025
Q2
$57.7K Buy
+5,120
New +$47K 0.01% 747
2024
Q3
Sell
-34,850
Closed -$666K 1288
2024
Q2
$666K Buy
34,850
+33,439
+2,370% +$854K 0.07% 227
2024
Q1
$46.3K Buy
+1,411
New +$45K 0.01% 739

Other funds holding EVH

Headlands Technologies's EVH Position: Q2 2026 in Review

Headlands Technologies increased its Evolent Health (EVH) stake by 72% in Q2 2026, buying an estimated $46.9K and bringing the position to 29,292 shares worth $159K. The position accounts for 0.02% of the portfolio, ranked #627.

Headlands Technologies first reported a position in EVH in Q1 2024 and has held it in 6 quarters since. The position peaked at $666K in Q2 2024. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Headlands Technologies held 29,292 shares of Evolent Health worth $159K as of Q2 2026.
  • Headlands Technologies bought 12,232 Evolent Health shares in Q2 2026, an estimated $46.9K.
  • Evolent Health made up 0.02% of Headlands Technologies's portfolio in Q2 2026, its #627 holding.
  • Headlands Technologies first reported a position in Evolent Health in Q1 2024 and has held it in 6 quarters since.
  • Headlands Technologies's Evolent Health position peaked at $666K in Q2 2024.
  • 198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Headlands Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.